Related Experiment Video
Updated: Jun 30, 2026

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
Platelet antistaphylococcal responses occur through P2X1 and P2Y12 receptor-induced activation and kinocidin release
Darin A Trier1, Kimberly D Gank, Deborah Kupferwasser
1Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center, Torrance, CA 90509, USA.
Abstract:
Platelets (PLTs) act in antimicrobial host defense by releasing PLT microbicidal proteins (PMPs) or PLT kinocidins (PKs). Receptors mediating staphylocidal efficacy and PMP or PK release versus isogenic PMP-susceptible (ISP479C) and -resistant (ISP479R) Staphylococcus aureus strains were examined in vitro. Isolated PLTs were incubated with ISP479C or ISP479R (PLT/S. aureus ratio range, 1:1 to 10,000:1) in the presence or absence of a panel of PLT inhibitors, including P2X and P2Y receptor antagonists of increasingly narrow specificity, and PLT adhesion receptors (CD41, CD42b, and CD62P). PLT-to-S. aureus exposure ratios of > or = 10:1 yielded significant reductions in the viability of both strains. Results from reversed-phase high-performance liquid chromatography indicated that staphylocidal PLT releasates contained PMPs and PKs. At ratios below 10:1, the PLT antistaphylococcal efficacy relative to the intrinsic S. aureus PMP-susceptible or -resistant phenotype diminished. Apyrase (an agent of ADP degradation), suramin (a general P2 receptor antagonist), pyridoxal 5'-phosphonucleotide derivative (a specific P2X(1) antagonist), and cangrelor (a specific P2Y(12) antagonist) mitigated the PLT staphylocidal response against both strains, correlating with reduced levels of PMP and PK release. Specific inhibition occurred in the presence and absence of homologous plasma. The antagonism of the thromboxane A(2), cyclooxygenase-1/cyclooxygenase-2, or phospholipase C pathway or the hindrance of surface adhesion receptors failed to impede PLT anti-S. aureus responses. These results suggest a multifactorial PLT anti-S. aureus response mechanism involving (i) a PLT-to-S. aureus ratio sufficient for activation; (ii) the ensuing degranulation of PMPs, PKs, ADP, and/or ATP; (iii) the activation of P2X(1)/P2Y(12) receptors on adjacent PLTs; and (iv) the recursive amplification of PMP and PK release from these PLTs.
Insights
Platelets (PLTs) kill Staphylococcus aureus by releasing microbicidal proteins (PMPs) and kinocidins (PKs). P2X(1) and P2Y(12) receptor activation amplifies this antimicrobial response, crucial for host defense.
Area of Science:
- Immunology
- Microbiology
- Hematology
Background:
- Platelets (PLTs) play a role in antimicrobial host defense.
- PLTs release microbicidal proteins (PMPs) and kinocidins (PKs) with antibacterial properties.
Purpose of the Study:
- To investigate the receptors mediating the staphylocidal efficacy of PLTs.
- To examine the release of PMPs and PKs against Staphylococcus aureus strains in vitro.
Main Methods:
- Isolated PLTs were incubated with isogenic PMP-susceptible and -resistant Staphylococcus aureus strains.
- PLT inhibitors targeting P2X and P2Y receptors, and adhesion receptors were used.
- Reversed-phase high-performance liquid chromatography analyzed releasates.
Main Results:
- A PLT-to-S. aureus ratio of ≥10:1 significantly reduced bacterial viability.
- P2X(1) and P2Y(12) receptor antagonists (e.g., pyridoxal 5'-phosphonucleotide derivative, cangrelor) mitigated the staphylocidal response and reduced PMP/PK release.
- Inhibition of thromboxane A(2), COX, PLC pathways, or adhesion receptors did not impede the anti-S. aureus response.
Conclusions:
- Platelet antimicrobial activity against S. aureus is multifactorial.
- Key mechanisms include sufficient PLT activation, degranulation of PMPs/PKs, P2X(1)/P2Y(12) receptor activation on adjacent PLTs, and amplification of PMP/PK release.
More Related Videos
Related Concept Videos
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Inflammation

